[1]
|
Anderson, F.A., Wheeler, H.B., Goldberg, R.J., et al. (1991) A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary Embolism. The Worcester DVT Study. Archives of Internal Medicine, 151, 933-938. https://doi.org/10.1001/archinte.1991.00400050081016
|
[2]
|
Kucher, N. (2011) Deep Vein Thrombosis of the Upper Extremities. The New England Journal of Medicine, 364, 861-869. https://doi.org/10.1056/NEJMcp1008740
|
[3]
|
Spyropoulous, A.C. and Lin, J. (2007) Direct Medical Costs of VTE and Subsequent Hospital Readmission Rates: An Administrative Claims Analysis from 30 Managed Care Organ-izations. Journal of Managed Care & Specialty Pharmacy, 13, 475-486. https://doi.org/10.18553/jmcp.2007.13.6.475
|
[4]
|
Mousa, A.Y. and AbuRahma, A.F. (2013) May-Thurner Syn-drome: Update and Review. Annals of Vascular Surgery, 27, 984-995. https://doi.org/10.1016/j.avsg.2013.05.001
|
[5]
|
Mall, N.A., Van Thiel, G.S., Heard, W.M., Paletta, G.A., Bush-Joseph, C. and Bach, B.R. (2013) Paget-Schroetter Syndrome: A Review of Effort Thrombosis of the Upper Ex-tremity from a Sports Medicine Perspective. Sports Health, 5, 353-356. https://doi.org/10.1177/1941738112470911
|
[6]
|
Falck-Ytter, Y., Francis, C.W., Johanson, N.A., et al. (2012) Prevention of VTE in Orthopedic Surgery Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e278S-e325S. https://doi.org/10.1378/chest.11-2404
|
[7]
|
Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Ei-senberg, P.R. and Miletich, J.P. (1995) Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myo-cardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men. The New England Journal of Medicine, 332, 912-917.
https://doi.org/10.1056/NEJM199504063321403
|
[8]
|
Poort, S.R., Rosendaal, F.R., Reitsma, P.H. and Bertina, R.M. (1996) A Common Genetic Variation in the 3’-Untranslated Region of the Prothrombin Gene Is Associated with Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis. Blood, 88, 3698-3703.
https://doi.org/10.1182/blood.V88.10.3698.bloodjournal88103698
|
[9]
|
Schafer, A.I. (1985) The Hypercoagulable States. Annals of Internal Medicine, 102, 814-828.
https://doi.org/10.7326/0003-4819-102-6-814
|
[10]
|
Rogers, J.S. (1993) Hypercoagulable States. West Virginia Medical Journal, 89, 61-63.
|
[11]
|
McGee, S. (2012) Evidence-Based Physical Diagnosis. Saunders, Philadelphia, 472-473.
https://doi.org/10.1016/B978-1-4377-2207-9.00001-X
|
[12]
|
Goodacre, S., Sutton, A.J. and Sampson, F.C. (2005) Meta-Analysis: The Value of Clinical Assessment in the Diagnosis of Deep Venous Thrombosis. Annals of Internal Medicine, 143, 129-139.
https://doi.org/10.7326/0003-4819-143-2-200507190-00012
|
[13]
|
Wells, P.S., Anderson, D.R., Bormanis, J., et al. (1997) Value of Assessment of Pretest Probability of Deep-Vein Thrombosis in Clinical Management. The Lancet, 350, 1795-1798. https://doi.org/10.1016/S0140-6736(97)08140-3
|
[14]
|
Wells, P.S., Anderson, D.R., Rodger, M., et al. (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. The New England Journal of Medicine, 349:1227-1235. https://doi.org/10.1056/NEJMoa023153
|
[15]
|
Bates, S.M., Kearon, C., Crowther, M., et al. (2003) A Diagnostic Strategy Involving a Quantitative Latex D-Dimer Assay Reliably Excludes Deep Venous Thrombosis. Annals of Internal Medicine, 138, 787-794.
https://doi.org/10.7326/0003-4819-138-10-200305200-00006
|
[16]
|
Tapson, V.F., Carroll, B.A., Davidson, B.L., et al. (1999) The Diagnostic Approach to Acute Venous Thromboembolism. American Journal of Respiratory and Critical Care Medicine, 160, 1043-1066.
https://doi.org/10.1164/ajrccm.160.3.16030
|
[17]
|
Hull, R., Hirsh, J., Sackett, D.L., et al. (1981) Clinical Validity of a Negative Venogram in Patients with Clinically Suspected Venous Thrombosis. Circulation, 64, 622-625. https://doi.org/10.1161/01.CIR.64.3.622
|
[18]
|
Kearon, C., Julian, J.A., Newman, T.E. and Ginsberg, J.S. (1998) Nonin-Vasive Diagnosis of Deep Venous Thrombosis. McMas-ter Diagnostic Imaging Practice Guidelines Initiative. Annals of Internal Medicine, 128, 663-677.
https://doi.org/10.7326/0003-4819-128-8-199804150-00011
|
[19]
|
Lensing, A.W. (1989) Detection of Deep-Vein Thrombosis by Real-Time B-Mode Ultrasonography. The New England Journal of Medicine, 320, 342-345. https://doi.org/10.1056/NEJM198902093200602
|
[20]
|
Mattos, M.A., Londrey, G.L., Leutz, D.W., et al. (1992) Color-Flow Duplex Scanning for the Surveillance and Diagnosis of Acute Deep Venous Thrombosis. Journal of Vas-cular Surgery, 15, 336-375.
https://doi.org/10.1016/0741-5214(92)90258-A
|
[21]
|
Kearon, C., Akl, E.A., Comerota, A.J., et al. (2012) An-tithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e419S-e494S. https://doi.org/10.1378/chest.11-2301
|
[22]
|
White, R.H., Brunson, A., Romano, P.S., Li, Z. and Wun, T. (2016) Outcomes after Vena Cava Filter Use in Noncancer Patients with Acute Venous Thromboembolism: A Population-Based Study. Circulation, 133, 2018-2029.
https://doi.org/10.1161/CIRCULATIONAHA.115.020338
|
[23]
|
Decousus, H., Leizorovicz, A., Parent, F., et al. (1998) A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. The New England Journal of Medicine, 338, 409-415.
https://doi.org/10.1056/NEJM199802123380701
|
[24]
|
Kearon, C., Akl, E.A., Ornelas, J., et al. (2016) An-tithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 149, 315-352. https://doi.org/10.1016/j.chest.2015.11.026
|
[25]
|
Einstein Investigators, Bauersachs, R., Berkowitz, S.D., Brenner, B., et al. (2010) Oral Rivaroxaban for Symptomatic Venous Thromboembolism. The New England Journal of Medicine, 363, 2499-2510.
https://doi.org/10.1056/NEJMoa1007903
|
[26]
|
Kovacs, M.J., Rodger, M., Anderson, D.R., et al. (2003) Compar-ison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboem-Bolism. A Randomized, Double-Blind, Controlled Trial. Annals of Internal Medicine, 138, 714-719.
https://doi.org/10.7326/0003-4819-138-9-200305060-00007
|
[27]
|
Agnes, Y.Y., Lee, M.D., Mark, N., et al. (2003) Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer. The New England Journal of Medicine, 349, 146-153.
https://doi.org/10.1056/NEJMoa025313
|